Protein RS1 (RSC1A1) Downregulates the Exocytotic Pathway of Glucose Transporter SGLT1 at Low Intracellular Glucose via Inhibition of Ornithine Decarboxylase

Mol Pharmacol. 2016 Nov;90(5):508-521. doi: 10.1124/mol.116.104521. Epub 2016 Aug 23.

Abstract

Na+-d-glucose cotransporter 1 (SGLT1) is rate-limiting for glucose absorption in the small intestine. Shortly after intake of glucose-rich food, SGLT1 abundance in the luminal membrane of the small intestine is increased. This upregulation occurs via glucose-induced acceleration of the release of SGLT1-containing vesicles from the trans-Golgi network (TGN), which is regulated by a domain of protein RS1 (RSC1A1) named RS1-Reg. Dependent on phosphorylation, RS1-Reg blocks release of vesicles containing SGLT1 or concentrative nucleoside transporter 1. The hypothesis has been raised that RS1-Reg binds to different receptor proteins at the TGN, which trigger release of vesicles with different transporters. To identify the presumed receptor proteins, two-hybrid screening was performed. Interaction with ornithine decarboxylase 1 (ODC1), the rate-limiting enzyme of polyamine synthesis, was observed and verified by immunoprecipitation. Binding of RS1-Reg mutants to ODC1 was characterized using surface plasmon resonance. Inhibition of ODC1 activity by RS1-Reg mutants and the ODC1 inhibitor difluoromethylornithine (DFMO) was measured in the absence and presence of glucose. In addition, short-term effects of DFMO, RS1-Reg mutants, the ODC1 product putrescine, and/or glucose on SGLT1 expressed in oocytes of Xenopus laevis were investigated. High-affinity binding of RS1-Reg to ODC1 was demonstrated, and evidence for a glucose binding site in ODC1 was provided. Binding of RS1-Reg to ODC1 inhibits the enzymatic activity at low intracellular glucose, which is blunted at high intracellular glucose. The data suggest that generation of putrescine by ODC1 at the TGN stimulates release of SGLT1-containing vesicles. This indicates a biomedically important role of ODC1 in regulation of glucose homeostasis.

MeSH terms

  • Animals
  • Biological Transport / drug effects
  • Caco-2 Cells
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Down-Regulation / drug effects*
  • Eflornithine / pharmacology
  • Electrophoresis, Polyacrylamide Gel
  • Exocytosis / drug effects*
  • Glucose / pharmacology*
  • HEK293 Cells
  • Humans
  • Immunoprecipitation
  • Intracellular Space / metabolism
  • Kinetics
  • Methylglucosides / pharmacology
  • Models, Biological
  • Monosaccharide Transport Proteins / chemistry
  • Monosaccharide Transport Proteins / metabolism*
  • Oocytes / drug effects
  • Oocytes / metabolism
  • Ornithine Decarboxylase / metabolism*
  • Phlorhizin / pharmacology
  • Protein Binding / drug effects
  • Protein Domains
  • Recombinant Proteins / metabolism
  • Sodium-Glucose Transporter 1 / metabolism*
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • Surface Plasmon Resonance
  • Xenopus laevis

Substances

  • Methylglucosides
  • Monosaccharide Transport Proteins
  • RSC1A1 protein, human
  • Recombinant Proteins
  • Sodium-Glucose Transporter 1
  • Phlorhizin
  • Ornithine Decarboxylase
  • Glucose
  • Eflornithine